Balance Sheet Breakdown: Stoke Therapeutics Inc (STOK)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $14.47 in the prior trading day, Stoke Therapeutics Inc (NASDAQ: STOK) closed at $14.72, up 1.73%. In other words, the price has increased by $1.73 from its previous closing price. On the day, 1.91 million shares were traded. STOK stock price reached its highest trading level at $14.8 during the session, while it also had its lowest trading level at $14.07.

Ratios:

Our goal is to gain a better understanding of STOK by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.67 and its Current Ratio is at 6.67. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 03 ’24 when Ticho Barry sold 10,000 shares for $14.95 per share. The transaction valued at 149,481 led to the insider holds 2,485 shares of the business.

Ticho Barry sold 10,000 shares of STOK for $145,843 on Aug 01 ’24. The CHIEF MEDICAL OFFICER now owns 2,485 shares after completing the transaction at $14.58 per share. On Aug 01 ’24, another insider, BARUCH TICHO, who serves as the Officer of the company, bought 30,000 shares for $14.97 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STOK now has a Market Capitalization of 774975616 and an Enterprise Value of 498821600. For the stock, the TTM Price-to-Sale (P/S) ratio is 51.12 while its Price-to-Book (P/B) ratio in mrq is 3.17. Its current Enterprise Value per Revenue stands at 32.91 whereas that against EBITDA is -4.447.

Stock Price History:

Over the past 52 weeks, STOK has reached a high of $17.58, while it has fallen to a 52-week low of $3.35. The 50-Day Moving Average of the stock is 2.57%, while the 200-Day Moving Average is calculated to be 41.07%.

Shares Statistics:

The stock has traded on average 589.38K shares per day over the past 3-months and 647070 shares per day over the last 10 days, according to various share statistics. A total of 45.92M shares are outstanding, with a floating share count of 39.42M. Insiders hold about 25.12% of the company’s shares, while institutions hold 95.95% stake in the company. Shares short for STOK as of 1724976000 were 9253286 with a Short Ratio of 15.70, compared to 1722384000 on 9815840. Therefore, it implies a Short% of Shares Outstanding of 9253286 and a Short% of Float of 26.319999.

Most Popular